Clinical Trial Update: PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PG2 in combination with chemoradiation for locally advanced esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• PG2

Snippet

Sponsor: PhytoHealth Corporation | Conditions: Cancer-related Fatigue, Survival | Phase 2 | Status: COMPLETED